b12 2500 mcg injection Walcobal-2500 Vitamin B12 Monthly Injection: Typical

## Combining Semaglutide with Supportive Therapies One advantage of transitioning from AOD-9604 to a GLP-1 **weight loss peptide** is the ability to complement the protocol with well-studied supportive therapies: ### NAD+ for Metabolic and Anti-Aging Support [NAD+ injections](/guides/nad-injection-benefits-anti-aging-energy-recovery-guide) support mitochondrial function, cellular energy production, and DNA repair all of which may be beneficial during active **fat loss**

The Bottom Line Although AOD-9604, MOTS-c, Tesamorelin, Semaglutide, and Tirzepatide are often discussed together, they serve very different purposes

Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties

Curious which weight-loss peptides medical patients are actually running